Arizona has no shortage of MedTech ambition. We have smart founders, credible research, and a growing pipeline of startups working on meaningful problems. But even the best ideas can hit a wall early for one simple reason: it is hard to get in front of clinicians in a structured way, early enough, and often enough to shape product development while it still matters. On January 29, 2026, MDM2 took a major step toward solving that challenge by launching its first CME-accredited

Sarah Stabenfeldt is trained in biomedical engineering. She earned her undergraduate degree from Saint Louis University with a focus on biomaterials, followed by a PhD in Bioengineering from Georgia Tech, where she specialized in  polymer based material systems for neurotrauma.  She then completed  an NIH funded postdoctoral fellowship jointly administered by Georgia Tech, Emory University, and Morehouse College, This program integrated advanced research with formal pedagogic

MDM2 and SEMI are committed to accelerating innovation at the intersection of semiconductors and MedTech. Arizona’s latest smart MedTech conference is just one of the latest ways we are supporting the MedTech community.